APA (7th ed.) Citation

CN, H., M, S., SS, A., RM, B., MR, P., ES, D., . . . MP, B. (2022). Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. JAMA network open, 5(6), e2215580. https://doi.org/10.1001/jamanetworkopen.2022.15580

Chicago Style (17th ed.) Citation

CN, Hess, et al. "Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization." JAMA Network Open 5, no. 6 (2022): e2215580. https://doi.org/10.1001/jamanetworkopen.2022.15580.

MLA (9th ed.) Citation

CN, Hess, et al. "Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization." JAMA Network Open, vol. 5, no. 6, 2022, p. e2215580, https://doi.org/10.1001/jamanetworkopen.2022.15580.